Related Experiment Videos
Contralateral cerebellar hypometabolism: a predictor for stroke outcome?
Journal of Neurology, Neurosurgery, and Psychiatry
|February 1, 1994
Summary
Contralateral cerebellar hypometabolism (CCH) does not reliably predict stroke outcome early after stroke. However, the absence of significant CCH in acute middle cerebral artery stroke may indicate a good prognosis.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Contralateral cerebellar hypometabolism (CCH) is a known remote functional consequence of cerebral injury.
- CCH has demonstrated reversibility in some acute stroke cases.
- Cerebellar metabolic asymmetry (CbMA) quantifies CCH and its predictive value for stroke outcomes is under investigation.
Purpose of the Study:
- To assess the value of CbMA as a predictor of stroke outcome in patients with acute middle cerebral artery territory stroke.
- To investigate the correlation between CbMA and neurological status and infarct size over time.
Main Methods:
- Positron emission tomography (PET) was used to measure cerebellar oxygen consumption in 16 patients within 5-30 hours of stroke onset.
- Follow-up PET scans were performed 13-56 days later in 12 survivors.
- Neurological status was assessed using Mathew and Orgogozo scales at multiple time points, and infarct size was determined by CT.
Main Results:
- Early CbMA measurements showed weak and inconsistent correlations with 60-day neurological outcome or recovery.
- Changes in CbMA from early to late scans did not correlate with neurological improvement.
- Late CbMA showed strong positive correlations with neurological status and infarct size, with neurological status explained by infarct size.
Conclusions:
- Early CbMA is a poor predictor of stroke outcome, potentially due to evolving cerebral metabolic disturbances.
- The absence of significant CCH in the early phase may predict a good outcome in acute middle cerebral artery stroke.
- Late CbMA correlates with neurological deficits and infarct size in the chronic stage post-stroke.